The Biostatistics Center is a research center of The George Washington University within the Milken Institute School of Public Health. The Center serves as the coordinating center for large scale multi-center clinical trials and epidemiologic studies. Founded in 1972, the BSC has a 46 year history of leadership in practice-changing clinical trials and biostatistical methodology research. Research studies conducted by the BSC have been: recognized in reports to the United States President and Congress, cited in reports from the United States White House, recognized in Time Magazine’s The Year in Medicine, named the #1 advance in medicine by the Harvard Health Letter, received the Society for Clinical Trials (SCT) “Trial of the Year” Award, received the Norman F. Gant Award for best research in maternal medicine, recognized in Clinical Research Forum’s Top Ten Awards, featured in People magazine, and resulted in more than 60 publications in the New England Journal of Medicine.
The Center’s mission is to:
•Provide leadership and expertise in the execution of clinical trials, observational studies, and diagnostic studies;
•Foster biostatistical science by developing and implementi...ng innovative approaches for the design, monitoring, analysis, and reporting of clinical research studies; and
•Provide training and education relevant to clinical trials and other clinical research.
The Center has a staff of approximately 120 with more than 40 biostatisticians/epidemiologists that includes more Fellows of the Society for Clinical Trials (SCT) than any other institution. Led by Professor Scott Evans, Director of the Center and principal investigator (PI) of the Statistical and Data Management Center (SDMC) of the Antibacterial Resistance Leadership Group (ARLG), the Center senior faculty includes renowned biostatisticians and former Center Directors Dr. John Lachin (PI of the Coordinating Centers for the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) and the Epidemiology of Diabetes Interventions and Complications (EDIC) studies) and Dr. Elizabeth Thom (PI of the Coordinating Center for the Maternal Fetal Medicine Units (MFMU)). Eighteen faculty members at the Center provide biostatistical leadership and manage $65-70 million annually for projects in medical areas such as diabetes, maternal fetal medicine, infectious disease, and cardiovascular disease.
For further information about the Center, please see: www.bsc.gwu.edu.